Lamb N J, Fernandez A, Conti M A, Adelstein R, Glass D B, Welch W J, Feramisco J R
Cold Spring Harbor Laboratory, New York 11724.
J Cell Biol. 1988 Jun;106(6):1955-71. doi: 10.1083/jcb.106.6.1955.
Microinjection of the catalytic subunit of cAMP-dependent protein kinase (A-kinase) into living fibroblasts or the treatment of these cells with agents that elevate the intracellular cAMP level caused marked alterations in cell morphology including a rounded phenotype and a complete loss of actin microfilament bundles. These effects were transient and fully reversible. Two-dimensional gel electrophoresis was used to analyze the changes in phosphoproteins from cells injected with A-kinase. These experiments showed that accompanying the disassembly of actin microfilaments, phosphorylation of myosin light chain kinase (MLCK) increased and concomitantly, the phosphorylation of myosin P-light chain decreased. Moreover, inhibiting MLCK activity via microinjection of affinity-purified antibodies specific to native MLCK caused a complete loss of microfilament bundle integrity and a decrease in myosin P-light chain phosphorylation, similar to that seen after injection of A-kinase. These data support the idea that A-kinase may regulate microfilament integrity through the phosphorylation and inhibition of MLCK activity in nonmuscle cells.
将环磷酸腺苷(cAMP)依赖性蛋白激酶(A激酶)的催化亚基显微注射到活的成纤维细胞中,或者用能提高细胞内cAMP水平的试剂处理这些细胞,会导致细胞形态发生显著改变,包括细胞变圆以及肌动蛋白微丝束完全消失。这些效应是短暂且完全可逆的。二维凝胶电泳用于分析注射了A激酶的细胞中磷蛋白的变化。这些实验表明,伴随着肌动蛋白微丝的解聚,肌球蛋白轻链激酶(MLCK)的磷酸化增加,同时,肌球蛋白P轻链的磷酸化减少。此外,通过显微注射针对天然MLCK的亲和纯化抗体来抑制MLCK活性,会导致微丝束完整性完全丧失以及肌球蛋白P轻链磷酸化减少,这与注射A激酶后观察到的情况相似。这些数据支持这样一种观点,即A激酶可能通过磷酸化和抑制非肌肉细胞中的MLCK活性来调节微丝的完整性。